Cardiac dysfunction was also more advanced in the hyperuricemia group than in the control group, as evidenced by the increased left atrial diameter, left atrial volume, and brain natriuretic peptide level; decreased left ventricular ejection fraction; and higher incidence of a history of heart failure in the hyperuricemia group. The gene discussed is NPPB; the disease is hyperuricemia.